Kymera Therapeutics Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 13:27:38 ET
More on Kymera Therapeutics
- Kymera Therapeutics: The More This Biotech Spends, The Higher Its Valuation Rises
- Kymera Therapeutics, Inc. (KYMR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Kymera Therapeutics, Inc. (KYMR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Kymera Therapeutics prices $602M public offering at $86.00 a share
- Kymera Therapeutics announces $500M proposed public offering
Read the full article on Seeking Alpha
For further details see:
Kymera Therapeutics Q4 2025 Earnings Preview
Kymera Therapeutics Inc.
NASDAQ: KYMR
KYMR Trading
3.15% G/L:
$84.06 Last:
173,598 Volume:
$82.85 Open:
KYMR Latest News
March 10, 2026 07:00:00 am
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
February 26, 2026 07:00:00 am
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
KYMR Stock Data
$6,259,529,627
60,213,376
0.01%
74
N/A
Biotechnology & Life Sciences
Healthcare
US
Watertown
